Universitaet Muenster

Analysis

Universitaet Muenster has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter represents the university's current engagement with the patent office in the life sciences sector. The presence of a pending action indicates a focused prosecution effort for the institution's biological intellectual property.

This active matter is assigned to 1 distinct examiner and a specific art unit. This concentration suggests that the university's technical developments are categorized within a very narrow specialized group. Madeline Mcguire Dekarske is the busiest examiner for the university, handling the pending office action. The alignment of all active work under this individual creates a centralized prosecution environment.

Practitioners should note that the results of the university's current patenting efforts are heavily influenced by the specific examination approach of Madeline Mcguire Dekarske. While this centralization simplifies the management of active cases, it also means the portfolio does not benefit from a diversity of examiner viewpoints. Future applications in the Biotechnology & Pharmaceuticals area are likely to remain within this art unit if they maintain similar technical claims.